Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen

British Journal of Cancer

Volumn 81, Issue 8, 1999, Pages 1269-1273

  Heidtmann, H H ^a   Nettelbeck, D M ^b   Mingels, A ^b   Jager R ^b   Welker, H G ^c   Kontermann, R E ^b  

^a StJoseph Hospital Bremerhaven   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Angiostatin; Anti angiogenesis; Plasminogen; Prostate cancer; PSA

Indexed keywords

ALANINE; ANGIOSTATIN; ANTIMITOTIC AGENT; GLUTAMIC ACID; PLASMINOGEN; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KRINGLE DOMAIN; METASTASIS; MICROVASCULATURE; MORPHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; TUMOR GROWTH; TUMOR VASCULARIZATION; UMBILICAL VEIN;

EID: 0032760205     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6692167     Document Type: Article

References (22)

1. Cao Y, Chen A, An SSA, Ji RW, Davidson D, Cao Y and Llinás M (1997) Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem 272: 22924-22928
2. Christensson A, Laurell C and Lilja H (1990) Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 194: 755-763
3. Dong Z, Kumar R, Yang X and Fidler IJ (1997) Macrophage derived metalloclastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88: 801-810
4. Gately S, Twardowski P, Stack MS, Patrick M, Boggio L, Cundiff DL, Schnaper HW, Madison L, Volpert O, Bouck N, Enghild J, Kwaan HC and Soff GA (1996) Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angioslatin. Cancer Rev 56: 4887-4890
5. Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, Kwaan HC, Lee F, Kramer RA, Volpert O, Bouck N and Soff GA (1997) The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA 94: 10868-10872
6. Hasenson M, Lundh B, Stege R, Carlstrom K and Pousette A (1989) PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: relation to hormone sensitivity and to cytological grading. Prostate 14: 83-90
7. Hayes MI. and Castellino FJ (1979) Carbohydrate of the human plasminogen variants J Biol Chem 254: 8772
8. Kumar R, Yoneda J, Bucana CD and Fidler IJ (1998) Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol 12: 749-757
9. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature (Lond.) 227: 680-685
10. Leinonen J, Zhang WM and Stenman UH (1996) Complex formation between PSA isoenzymes and protease inhibitors. J Urol 155: 1099-1103
11. Lilja HR, Abrahamsson P-A and Lundwall A (1989) Semenogelin, the predominant protein in human semen. J Biol Chem 264: 18894-1900
12. Lilja HR, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Petersson K and Lövgren T (1991) Prostate specific antigen in human serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 37: 1618-1625
13. Lijnen HR, Uguwu F, Biui A and Collen D (1998) Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37: 4699-4702
14. Malm J, Hellman J and Lilja H (1997) Mapping of the unique enzyme characteristic of PSA. J Urol 157: 345
15. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage FH and Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328
16. O'Reilly MS, Holmgren L, Chen C and Folkman J (1996) Angiostatin induces and sustains dormnacy of human primary tumours in mice. Nat Med 2: 689-692
17. Patterson BC and Sang QA (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272: 28823-28825
18. Shi GY and Wu HL (1988) Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen. J Biol Chem 263: 17071-17075
19. Sottrup-Jensen L, Claeys H, Zajdel M, Petersson TE and Magnusson S (1978) The primary structure of human plasminogen: isolation of two lysine-binding fragments and one 'mini'-plasminogen (MW 38 000) by elastase-catalyzed specific limited proteolysis. In: Progress in Chemical Fibrinolysis and Thrombolysis, Vol. 3, Davidson JF, Rowan RM, Samama MM and Desnoyers PC (eds), pp. 191. Raven Press: New York
20. Sottrup-Jensen L, Lonblad PB, Stepanik TM, Petersen TE, Magnusson S and Jornvall H (1981) Primary structure of the 'bait' region for proteinases in alpha 2 macroglobulin. Nature of the complex. FEBS Lett 127: 167-173
21. Wallén P and Wiman B (1972) Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. Biochem Biophys Acta 257: 122-129
22. Zhang WM, Leinonen J, Kalkkinen N, Dowell B and Stenman UH (1995) Purification and characterization of different forms of prostate-specific antigen in human seminal fluid. Clin Chem 41: 1567-1573